|
1
|
Ostridge K, Williams N, Kim V, Harden S,
Bourne S, Coombs NA, Elkington PT, Estepar RS, Washko G, Staples KJ
and Wilkinson TM: Distinct emphysema subtypes defined by
quantitative CT analysis are associated with specific pulmonary
matrix metalloproteinases. Respir Res. 17:922016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papakonstantinou E, Karakiulakis G,
Batzios S, Savic S, Roth M, Tamm M and Stolz D: Acute exacerbations
of COPD are associated with significant activation of matrix
metalloproteinase 9 irrespectively of airway obstruction, emphysema
and infection. Respir Res. 16:782015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith BM, Austin JH, Newell JD Jr, D'Souza
BM, Rozenshtein A, Hoffman EA, Ahmed F and Barr RG: Pulmonary
emphysema subtypes on computed tomography: The MESA COPD study. Am
J Med. 127:94.e7–e23. 2014. View Article : Google Scholar
|
|
4
|
Foster WL Jr, Pratt PC, Roggli VL, Godwin
JD, Halvorsen RA Jr and Putman CE: Centrilobular emphysema:
CT-pathologic correlation. Radiology. 159:27–32. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hruban RH, Meziane MA, Zerhouni EA, Khouri
NF, Fishman EK, Wheeler PS, Dumler JS and Hutchins GM: High
resolution computed tomography of inflation-fixed lungs.
Pathologic-radiologic correlation of centrilobular emphysema. Am
Rev Respir Dis. 136:935–940. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Montaño M, Sansores RH, Becerril C,
Cisneros J, González-Avila G, Sommer B, Ochoa L, Herrera I,
Ramírez-Venegas A and Ramos C: FEV1 inversely correlates with
metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke
exposure. Respir Res. 15:742014.PubMed/NCBI
|
|
7
|
Grzela K, Litwiniuk M, Zagorska W and
Grzela T: Airway remodeling in chronic obstructive pulmonary
disease and asthma: The role of matrix metalloproteinase-9. Arch
Immunol Ther Exp (Warsz). 64:47–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jia TG, Zhao JQ and Liu JH: Serum
inflammatory factor and cytokines in AECOPD. Asian Pac J Trop Med.
7:1005–1008. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Divo M, Cote C, de Torres JP, Casanova C,
Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J,
Hunninghake G, et al: Comorbidities and risk of mortality in
patients with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med. 186:155–161. 2002. View Article : Google Scholar
|
|
10
|
Celli BR and MacNee W; ATS/ERS Task Force,
: Standards for the diagnosis and treatment of patients with COPD:
A summary of the ATS/ERS position paper. Eur Respir J. 23:932–946.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kitaguchi Y, Fujimoto K, Kubo K and Honda
T: Characteristics of COPD phenotypes classified according to the
findings of HRCT. Respir Med. 100:1742–1752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roberts HR, Wells AU, Milne DG, Rubens MB,
Kolbe J, Cole PJ and Hansell DM: Airflow obstruction in
bronchiectasis: Correlation between computed tomography features
and pulmonary function tests. Thorax. 55:198–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
The definition of emphysema. Report of a
National Heart, Lung, and Blood Institute, Division of Lung
Diseases workshop. Am Rev Respir Dis. 132:182–185. 1985.PubMed/NCBI
|
|
14
|
Hoffman EA, Simon BA and Mclennan G: State
of the art. A structural and functional assessment of the lung via
multidetector-row computed tomography: Phenotyping chronic
obstructive pulmonary disease. Proc Am Thorac Soc. 3:519–532. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh S, Loke YK, Enright PL and Furberg
CD: Mortality associated with tiotropium mist inhaler in patients
with chronic obstructive pulmonary disease: Systematic review and
meta-analysis of randomised controlled trials. BMJ. 342:d32152011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dar KA, Shahid M, Mubeen A, Bhargava R,
Ahmad Z, Ahmad I and Islam N: The role of noninvasive methods in
assessing airway inflammation and structural changes in asthma and
COPD. Monaldi Arch Chest Dis. 77:8–18. 2012.PubMed/NCBI
|
|
17
|
Kwiatkowska S, Noweta K, Zieba M, Nowak D
and Bialasiewicz P: Enhanced exhalation of matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in
patients with COPD exacerbation: A prospective study. Respiration.
84:231–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Linder R, Rönmark E, Pourazar J, Behndig
A, Blomberg A and Lindberg A: Serum metallopteinase-9 is related to
COPD severity and symptoms-cross-sectional data from a population
based cohort-study. Respir Res. 16:282015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anderson AE Jr and Foraker AG:
Centrerilobolar emphysema and panlobular emphysema: Two different
diseases. Thorax. 28:547–550. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saetta M, Kim WD, Izquierdo JL, Ghezzo H
and Cosio MG: Extent of centriobular and panacinar emphysema in
smokers'lungs: Pathological and mechanical implications. Eur Respir
J. 7:664–671. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kawayama T, Kinoshita T, Matsunaga K,
Kobayashi A, Hayamizu T, Johnson M and Hoshino T: Responsiveness of
blood and sputum inflammatory cells in Japanese copd patients,
non-copd smoking controls, and non-copd nonsmoking controls. Int J
Chron Obstruct Pulmon Dis. 11:295–303. 2016.PubMed/NCBI
|
|
22
|
Segura-Valdezl L, Pardo A, Gaxiola M, Uhal
BD, Becerril C and Selman M: Upregulation of gelatinases A and B,
collagenases 1 and 2, and increased parenchymal cell death in COPD.
Chest. 117:684–694. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Linder R, Rönmark E, Pourazar J, Behndig
A, Blomberg A and Lindberg A: Serum metalloproteinase-9 is related
to COPD severity and symptoms-cross-sectional data from a
population based cohort-study. Respir Res. 16:282015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong Y, Ji W, An S, Han SS, Lee SJ and Kim
WJ: Sex differences of COPD phenotypes in nonsmoking patiens. Int J
Chron Obstruct Pulmon Dis. 11:1657–1662. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim V, Han MK, Vance GB, Make BJ, Newell
JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK and Criner GJ;
COPDGene Investigators, : The chronic bronchitic phenotype of COPD:
An analysis of the COPDGene study. Chest. 140:626–633. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith MC and Wrobel JP: Epidemiology and
clinical impact of major comorbidities in patients with COPD. Int J
Chron Obstruct Pulmon Dis. 9:871–888. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Selvarajah S, Todd I, Tighe PJ, John M,
Bolton CE, Harrison T and Fairclough LC: Multiple Circulating
cytokines are coelevated in chronic obstrictive pulmonary disease.
Mediators Inflamm. 2016:36048422016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eickhoff P, Valipour A, Kiss D, Schreder
M, Cekici L, Geyer K, Kohansal R and Burghuber OC: Determinants of
systemic vascular function in patients wity stable chronic
obstructive pulmonary disease. Am J Respir Crit Care Med.
178:1211–1218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wells JM, Washko GR, Han MK, Abbas N, Nath
H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, et al:
Pulmonary arterial enlargement and acute exacerbations of COPD. N
Engl Med. 367:913–921. 2012. View Article : Google Scholar
|
